title: [Treatment of bladder neoplasm: vesical instillation of BCG vaccine in microdoses].
abstract: We administered BCG at microdoses (1 mg) to 34 patients after surgical operation for bladder cancer, from 1981 to 1989. A 9% recurrency rate was observed during a 42 month follow up period. This is not significantly different from that observed with 120 mg doses, which are associated to known complications.
authors.affiliation: Servicio de Urología, Facultad de Medicina, Universidad de La Frontera, Hospital Regional de Temuco, Chile.
authors.forename: P
authors.initials: P
authors.lastname: Rivera
authors.forename: M
authors.initials: M
authors.lastname: Gorena
authors.forename: J
authors.initials: J
authors.lastname: Hinostroza
authors.forename: P
authors.initials: P
authors.lastname: Pastor
authors.forename: P
authors.initials: P
authors.lastname: Venegas
mesh_terms: D001500:BCG Vaccine / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000601:surgery / Q000628:therapy*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009364:Neoplasm Recurrence, Local; D001749:Urinary Bladder Neoplasms / Q000601:surgery / Q000628:therapy*
chemical_list: D001500:BCG Vaccine
vernacular_title: Tratamiento del cáncer de la vejiga: instilación vesical de microdosis de vacuna BCG.